title: Report on the First PANLAR Rheumatology Review Course Rheumatoid Arthritis: Challenges and Solutions in Latin America.
abstract: The First PANLAR Rheumatology Review Course was held in Barranquilla, Colombia, in April 2015. Researchers, rheumatologists, epidemiologists, and a variety of allied professionals and patients attended the meeting. The scientific program included plenary sessions and symposia delivered by renowned experts in the field, followed by an interactive forum of discussion during 2 days.A broad spectrum of topics was discussed, reflecting the current challenges and opportunities for diagnosis and treatment of rheumatoid arthritis (RA) in Latin America. The scientific program included not only traditional disease aspects, but also social implications, research projects, and educational characteristics, patient perspectives, and novel care models, emphasizing the need for training human resources and proposing unique approaches to RA health care in Latin America, therefore helping us to increase and improve the knowledge and understanding of the characteristics of this health condition in the region, thus promoting and encouraging equity, quality, and efficiency of RA health care.
authors.affiliation: From the *Instituto Nacional de Rehabilitación, Mexico City, Mexico; †Caballero-Uribe CV, MD, Universidad del Norte, Barranquilla, Colombia; ‡Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina; §Hospital General Dr Miguel Silva, Morelia, Michoacán, Mexico; ║Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil; ¶Hospital de Niños Ricardo Gutiérrez, Buenos Aires, Argentina; #DuPont Institute, Wilmington, DE; **Biomab Center for Rheumatoid Arthritis, Bogota, Colombia; ††Hospital Provincial de Rosario, Rosario, Santa Fe, Argentina; ‡‡Hospital Docente Padre Billini, Santo Domingo, Dominican Republic; §§Hospital Italiano de Buenos Aires, Buenos Aires Argentina; and ║║The University of Texas Health Science Center at Houston, Houston, TX.
authors.forename: Carlos
authors.initials: C
authors.lastname: Pineda
authors.forename: Carlo V
authors.initials: CV
authors.lastname: Caballero-Uribe
authors.forename: Marwin
authors.initials: M
authors.lastname: Gutiérrez
authors.forename: Tomás
authors.initials: T
authors.lastname: Cazenave
authors.forename: Mario H
authors.initials: MH
authors.lastname: Cardiel
authors.forename: Roger
authors.initials: R
authors.lastname: Levy
authors.forename: Graciela
authors.initials: G
authors.lastname: Espada
authors.forename: Carlos
authors.initials: C
authors.lastname: Rose
authors.forename: Pedro
authors.initials: P
authors.lastname: Santos-Moreno
authors.forename: Bernardo A
authors.initials: BA
authors.lastname: Pons-Estel
authors.forename: Roberto
authors.initials: R
authors.lastname: Muñoz-Louis
authors.forename: Enrique R
authors.initials: ER
authors.lastname: Soriano
authors.forename: John D
authors.initials: JD
authors.lastname: Reveille
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000175:diagnosis / Q000628:therapy; D003695:Delivery of Health Care / Q000379:methods / Q000458:organization & administration; D019468:Disease Management; D006801:Humans; D007843:Latin America; D010353:Patient Education as Topic; D058996:Quality Improvement; D012219:Rheumatology / Q000193:education / Q000379:methods; D012959:Socioeconomic Factors; D013192:Staff Development
chemical_list: D018501:Antirheumatic Agents